Parens Fertility
5.0
Parens Fertility: Where Dreams Come TrueWe're your trusted IVF agency, committed to transparent, high-quality care. With empathy and passion, we simplify the journey to parenthood.
Discover best doctors & clinics
Explore Early Embryo Viability Assessment
Early Embryo Viability Assessment (EEVA) is transforming the way fertility specialists approach IVF, offering a cutting-edge method for selecting the most viable embryos. This advanced technology enables doctors to assess embryo quality early in the development process, increasing the chances of a successful pregnancy and minimizing the need for multiple embryo transfers.
Popular Countries in Early Embryo Viability Assessment
Top rated doctors & clinics in Early Embryo Viability Assessment
treatmentsClear
language
service
Wireless Access(7)
Parking(6)
Public Transport Access(6)
Text Message Reminders(6)
International Travel(5)
- Ukraine, Lviv
Ireland, Dublin
Thérapie Fertility
5.0The most budget-friendly Fertility Clinic in Ireland, Thérapie Fertility, proudly operates as a completely Irish-owned establishment.
Languages Spoken:English
United Arab Emirates, Abu Dhabi
ART Fertility Clinics
5.0In the heart of the Middle East, ART Fertility Clinics in Abu Dhabi, Dubai, Al Ain, and Muscat have been instrumental in fulfilling the aspirations of countless couples, enabling them to embrace the joys of parenthood with the highest success rates in the entire region. The dedicated team at ART Fertility is steadfast in their commitment to providing you with the knowledge and support needed to make well-informed decisions on your journey towards parenthood.
Turkey, İstanbul
MD. Furkan Kayabaşoğlu - Ataşehir
5.0Dr. Kayabaşoğlu began working at the Private Koşuyolu Women's Diseases Center, which focuses on gynecological endoscopic surgery, at the beginning of 2011. In January 2013, he joined the team at the Kadıköy Şifa Health Group IVF Unit, and later that year, he successfully completed the Turkish Ministry of Health IVF and Reproductive Treatment Certification Program at the VKV American Hospital IVF Center.In May 2014, Furkan Kayabaşoğlu founded ALLE with his fellow physicians. He continues to oversee all patient follow-ups, particularly in the areas of reproductive and IVF treatments, at ALLE Health. In 2019, he started offering educational programs for expectant parents, which he named "Campalle." These weekend-long programs, which are held according to a predetermined schedule, continue to be offered today.
Turkey, İstanbulMD. Serkan Oral
5.0Serkan Oral is a fertility specialist and IVF doctor in Istanbul, Turkey. He is the founder of the Serkan Oral Fertility Center, which has been in operation since 2007. Dr. Oral is a graduate of the Istanbul University Cerrahpaşa Medical School and completed his residency in Obstetrics and Gynecology at the same institution. He then went on to specialize in Reproductive Medicine and Infertility at the American University of Beirut. Dr. Oral is a member of the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). He is also a certified IVF specialist by the American Board of Obstetrics and Gynecology
Turkey, AnkaraAssoc. Dr. Ali SEVEN - Anka Fertil
5.0Assoc. Dr. Ali Seven was born in Polatlı, Ankara in 1981 and completed his primary and secondary education in the capital city. Entering Kırıkkale Science High School in 1995 marked the commencement of his high school education, and he graduated from Ankara Anıttepe High School in 1998. In that same year, Dr. Seven enrolled at Gazi University Faculty of Medicine. After seven years of study, including one year of English preparation, he successfully obtained his Medical Doctor title upon graduating from Gazi University Faculty of Medicine in 2005.His journey into specialization began with his accomplishment in the September 2005 TUS (specialization exam), leading him to start his specialized training in Gynecology and Obstetrics at Ankara Training and Research Hospital in November of the same year. Following 4.5 years of dedicated efforts, Dr. Ali Seven earned the title of Obstetrics and Gynecology Specialist in May 2010.
Turkey, İstanbulMD. Arzu Cagdas
5.0Dr. Arzu Çağdaş is a distinguished fertility specialist known for her groundbreaking contributions to reproductive medicine. With over two decades of experience, Dr. Çağdaş has become a beacon of hope for countless individuals striving to overcome fertility challenges.Her approach to patient care is characterized by a unique blend of empathy, expertise, and innovation. Dr. Çağdaş believes in personalized treatment plans tailored to each individual or couple, understanding that fertility issues can be multifaceted and deeply personal. Her commitment to providing comprehensive care encompasses not only advanced medical techniques but also emotional support and guidance throughout the journey to conception.
Discover Treatments in Fertility
Browse treatments of Fertility in wupdoc from A-Z.
Most Popular Fertility Treatments
FAQ ABOUT Explore Early Embryo Viability Assessment
Browse frequently asked questions about explore early embryo viability assessment
Who should consider using EEVA?
EEVA is ideal for IVF patients with multiple embryos, especially those with a history of failed cycles or poor embryo quality, as it boosts success rates without multiple transfers.
How does EEVA improve the chances of IVF success?
By providing detailed and objective data on embryo development, EEVA helps embryologists select the best embryos for transfer. This selection depends on the embryos' observed potential for viability. It can lead to higher implantation rates, improved pregnancy outcomes, and possibly reduced rates of miscarriage.
Is the EEVA process invasive or harmful to the embryos?
EEVA is entirely non-invasive; it monitors embryos using time-lapse photography within a controlled incubation environment. There is no physical interference with the embryos, ensuring they remain undisturbed and in optimal conditions for development.
Can EEVA be used in all IVF cycles?
While EEVA is a valuable tool, its application may depend on specific clinic protocols and patient circumstances. It is most beneficial in IVF cycles where there are multiple embryos to assess. Thus, it allows for the best possible selection. However, individuals should discuss its use with a fertility specialist to determine its suitability for their specific cases.
What are the limitations of EEVA?
While EEVA can significantly enhance embryo selection, it does not guarantee a successful pregnancy. Other factors play critical roles in the success of an IVF cycle. These include uterine receptivity, maternal health, and genetic factors. Additionally, EEVA's predictions depend on developmental patterns and do not assess genetic health.
Related Articles
See All
Explore Early Embryo Viability Assessment
Early Embryo Viability Assessment (EEVA) is an innovative technology used in the field of assisted reproductive technology (ART). It predicts the potential of embryos, enhancing the chances of a successful pregnancy. This guide provides an in-depth look at EEVA. It details its methodology, applications, global practices, costs, availability, and the pros and cons associated with its use.
What is the Treatment?
EEVA is a non-invasive procedure. It employs time-lapse imaging to monitor and analyze embryo development during the critical early stages post-fertilization. By using advanced algorithms, EEVA predicts the embryos' potential for successful implantation and further development. It aids embryologists in selecting the best embryos for transfer during in vitro fertilization (IVF) procedures.
Treatment Process
The EEVA process integrates seamlessly with standard IVF protocols:
- Embryo Culture: After fertilization, they place embryos in a special incubator equipped with a time-lapse camera system.
- Continuous Monitoring: The EEVA system captures images of the embryos at frequent intervals, tracking their development without disturbing the culture environment.
- Data Analysis: Using patented software, EEVA analyzes specific developmental parameters of embryos to determine their potential.
- Embryo Selection: Based on EEVA's analysis, embryologists can identify and select the most viable embryos for transfer.
Popular Countries for the Treatment and Their Average Prices
EEVA technology is increasingly available worldwide, though its adoption may vary. Some countries where EEVA is more commonly found include:
- United States: The cost of adding EEVA to an IVF cycle ranges from €900 to €4,500 (approximately $1,000 to $5,000), depending on the clinic.
- United Kingdom: Leading fertility clinics in the UK may offer EEVA, with additional costs typically ranging from €1,200 to €3,000 on top of standard IVF fees.
- Spain: Known for its advanced fertility clinics, Spain offers EEVA as part of its comprehensive IVF services. Prices vary by clinic, generally ranging from €1,000 to €2,500.
- Turkey: Fertility clinics in Turkey also offer EEVA, with prices ranging from €800 to €2,500, making it an affordable option for many patients.
- Ireland: In Ireland, the cost of adding EEVA to an IVF cycle generally ranges from €1,000 to €3,000, depending on the clinic.
These prices can vary by clinic and region, so it’s recommended to inquire directly with fertility centers for the most accurate and up-to-date information.
Finding the Treatment Nearby
To find clinics that offer EEVA, prospective patients can use online platforms like Wupdoc. It provides a directory of fertility clinics worldwide, detailed service descriptions, user reviews, and ratings. This can help individuals locate clinics that utilize the latest technologies like EEVA in their IVF treatments.
Benefits and Harms of the Treatment
Benefits:
- Improved Selection: EEVA provides a more objective and detailed assessment of embryo development, potentially increasing the chances of selecting viable embryos for transfer.
- Reduced Multiple Pregnancy Risks: By identifying the most viable embryos, EEVA can support single embryo transfer strategies, reducing the risks associated with multiple pregnancies.
- Enhanced Success Rates: By optimizing embryo selection, EEVA may improve the overall success rates of IVF cycles.
Harms/Risks:
- Cost: EEVA can add a significant cost to an already expensive IVF treatment.
- Availability: Not all clinics offer EEVA technology, which may limit access for some patients.
- Not a Guarantee: EEVA can improve the odds of selecting viable embryos. However, it does not guarantee pregnancy or live birth.
In summary, Early Embryo Viability Assessment represents a significant advancement in the field of reproductive medicine. Thus, it offers a sophisticated tool to enhance embryo selection during IVF. However, patients should consider the additional cost and availability when deciding to incorporate EEVA into their fertility treatment plans.
However, patients should consider the additional cost and availability of EEVA when deciding whether to incorporate it into their fertility treatment plans. While EEVA can significantly improve the chances of success, it is important to weigh the financial investment against the potential benefits. Costs can vary depending on the clinic and country, and not all fertility centers may offer this technology. Additionally, patients should consult with their fertility specialists to determine if EEVA is right for their specific needs and circumstances, taking into account factors such as age, reproductive history, and the quality of embryos produced during previous cycles.
Ultimately, EEVA represents an exciting option for patients looking to optimize their IVF outcomes, but careful consideration and personalized advice from a fertility expert are essential in making the best decision.